159 related articles for article (PubMed ID: 24081795)
1. Ovarian cancer: a brief historical overview of intraperitoneal trials.
Kwa M; Muggia F
Ann Surg Oncol; 2014 May; 21(5):1429-34. PubMed ID: 24081795
[TBL] [Abstract][Full Text] [Related]
2. Toxicities, complications, and clinical encounters during intraperitoneal chemotherapy in 17 women with ovarian cancer.
Sun V; Otis-Green S; Morgan R; Wakabayashi M; Hakim A; Callado ME; Yang E; Ferrell B; Grant M
Eur J Oncol Nurs; 2013 Jun; 17(3):375-80. PubMed ID: 23153453
[TBL] [Abstract][Full Text] [Related]
3. [INTRAVENOUS CHEMOTHERAPY VERSUS INTRAPERITONEAL CHEMOTHERAPY IN ADVANCED OVARIAN CANCER: UPDATE ON THE SITUATION WORLDWIDE AND IN ISRAEL].
Binyamin S; Segev Y; Auslender R; Bitterman A; Lavie O
Harefuah; 2015 Sep; 154(9):594-8, 607, 606. PubMed ID: 26665753
[TBL] [Abstract][Full Text] [Related]
4. New and emerging intraperitoneal (IP) drugs for ovarian cancer treatment.
Muggia FM
Semin Oncol; 2006 Dec; 33(6 Suppl 12):S18-24. PubMed ID: 17223446
[TBL] [Abstract][Full Text] [Related]
5. Intraperitoneal chemotherapy for ovarian cancer.
Hamilton CA; Berek JS
Curr Opin Oncol; 2006 Sep; 18(5):507-15. PubMed ID: 16894301
[TBL] [Abstract][Full Text] [Related]
6. Intraperitoneal chemotherapy in the management of ovarian cancer.
Markman M
Recent Results Cancer Res; 2007; 169():165-76. PubMed ID: 17506259
[No Abstract] [Full Text] [Related]
7. Should intraperitoneal chemotherapy be considered as standard first-line treatment in advanced stage ovarian cancer?
Petignat P; du Bois A; Bruchim I; Fink D; Provencher DM
Crit Rev Oncol Hematol; 2007 May; 62(2):137-47. PubMed ID: 17188887
[TBL] [Abstract][Full Text] [Related]
8. [Intraperitoneal chemotherapy in ovarian carcinoma].
Piura B
Harefuah; 2001 Sep; 140(9):844-9, 894, 893. PubMed ID: 11579736
[TBL] [Abstract][Full Text] [Related]
9. Intraperitoneal chemotherapy for patients with advanced ovarian cancer: a review of the evidence and standards for the delivery of care.
Fung-Kee-Fung M; Provencher D; Rosen B; Hoskins P; Rambout L; Oliver T; Gotlieb W; Covens A;
Gynecol Oncol; 2007 Jun; 105(3):747-56. PubMed ID: 17368522
[TBL] [Abstract][Full Text] [Related]
10. An outpatient intraperitoneal chemotherapy regimen for advanced ovarian cancer.
Berry E; Matthews KS; Singh DK; Buttin BM; Lurain JR; Alvarez RD; Schink J
Gynecol Oncol; 2009 Apr; 113(1):63-7. PubMed ID: 19201457
[TBL] [Abstract][Full Text] [Related]
11. Intraperitoneal chemotherapy for ovarian cancer: overview and perspective.
Rao G; Crispens M; Rothenberg ML
J Clin Oncol; 2007 Jul; 25(20):2867-72. PubMed ID: 17617517
[TBL] [Abstract][Full Text] [Related]
12. Practice patterns of intraperitoneal chemotherapy in women with ovarian cancer.
Naumann RW; Sukumvanich P; Edwards RP
Gynecol Oncol; 2009 Jul; 114(1):37-41. PubMed ID: 19410281
[TBL] [Abstract][Full Text] [Related]
13. Completion of intraperitoneal chemotherapy in advanced ovarian cancer and catheter-related complications.
Lesnock JL; Richard SD; Zorn KK; Krivak TC; Beriwal S; Sukumvanich P; McBee WC; Kelley JL; Edwards RP
Gynecol Oncol; 2010 Mar; 116(3):345-50. PubMed ID: 19959211
[TBL] [Abstract][Full Text] [Related]
14. [Controversies regarding intraperitoneal chemotherapy for advanced ovarian cancer].
Miron L; Onofriescu M; Marinca M
Rev Med Chir Soc Med Nat Iasi; 2008; 112(3):583-9. PubMed ID: 20201236
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy of advanced ovarian cancer.
Martoni A; Cacciari N; Angelelli B; Zamagni C; Pannuti F
Front Biosci; 1997 Mar; 2():g20-6. PubMed ID: 9159262
[TBL] [Abstract][Full Text] [Related]
16. Intraperitoneal cisplatin and paclitaxel versus intravenous carboplatin and paclitaxel chemotherapy for Stage III ovarian cancer: a cost-effectiveness analysis.
Bristow RE; Santillan A; Salani R; Diaz-Montes TP; Giuntoli RL; Meisner BC; Armstrong DK; Frick KD
Gynecol Oncol; 2007 Sep; 106(3):476-81. PubMed ID: 17688927
[TBL] [Abstract][Full Text] [Related]
17. Primary surgery or neoadjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancer.
Vergote I; Amant F; Kristensen G; Ehlen T; Reed NS; Casado A
Eur J Cancer; 2011 Sep; 47 Suppl 3():S88-92. PubMed ID: 21944035
[TBL] [Abstract][Full Text] [Related]
18. Intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: a Gynecologic Oncology Group Study.
Walker JL; Armstrong DK; Huang HQ; Fowler J; Webster K; Burger RA; Clarke-Pearson D
Gynecol Oncol; 2006 Jan; 100(1):27-32. PubMed ID: 16368440
[TBL] [Abstract][Full Text] [Related]
19. Intraperitoneal chemotherapy for women with ovarian cancer: nursing care and considerations.
Potter KL; Held-Warmkessel J
Clin J Oncol Nurs; 2008 Apr; 12(2):265-71. PubMed ID: 18390462
[TBL] [Abstract][Full Text] [Related]
20. Is there a role for intraperitoneal chemotherapy in the management of ovarian cancer?
Markman M
Oncology (Williston Park); 2001 Jan; 15(1):93-8; discussion 103-5. PubMed ID: 11271985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]